The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
Open accessAbstract
Fungal bloodstream infections are associated with significant patient mortality and health care costs. Nevertheless, the relationship between a delay of the initial empiric antifungal treatment until blood culture results are known and the clinical outcome is not well established. A retrospective cohort analysis with automated patient medical records and the pharmacy database at Barnes-Jewish Hospital was conducted. One hundred fifty-seven patients with a Candida bloodstream infection were identified over a 4-year period (January 2001 through December 2004). Fifty (31.8%) patients died during hospitalization. One hundred thirty-four patients had empiric antifungal treatment begun after the results of fungal cultures were known. From the time that the first blood sample for culture that was positive was drawn, 9 (5.7%) patients received antifungal treatment within 12 h, 10 (6.4%) patients received antifungal treatment between 12 and 24 h, 86 (54.8%) patients received antifungal treatment between 24 and 48 h, and 52 (33.1%) patients received antifungal treatment after 48 h. Multiple logistic regression analysis identified Acute Physiology and Chronic Health Evaluation II scores (one-point increments) (adjusted odds ratio [AOR], 1.24; 95% confidence interval [CI], 1.18 to 1.31; P < 0.001), prior antibiotic treatment (AOR, 4.05; 95% CI, 2.14 to 7.65; P = 0.028), and administration of antifungal treatment 12 h after having the first positive blood sample for culture (AOR, 2.09; 95% CI, 1.53 to 2.84; P = 0.018) as independent determinants of hospital mortality. Administration of empiric antifungal treatment 12 h after a positive blood sample for culture is drawn is common among patients with Candida bloodstream infections and is associated with greater hospital mortality. Delayed treatment of Candida bloodstream infections could be minimized by the development of more rapid diagnostic techniques for the identification of Candida bloodstream infections. Alternatively, increased use of empiric antifungal treatment in selected patients at high risk for fungal bloodstream infection could also reduce delays in treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Finally, in a study of 10,811 patients treated in four Utah hospitals, each hour delay in time from ED arrival to administration of antimicrobials was associated with 1.16 increased odds of in-hospital and 1.10 increased odds of 1-year mortality (1.13 in patients with hypotension vs 1.09 in patients without hypotension) (111).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As mentioned previously, diagnosis of invasive candidiasis and candidemia remains a great challenge, since symptoms and signs are usually non-specific, microbiological cultures are difficult to analyze, and histological specimens require invasive procedures [29,30,46].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Attributable mortality from IC remains high and increases with delays in treatment.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Blood cultures take an average of 2–3 days to grow Candida, or longer depending on the species.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [136]
Experimental — accuracy not yet measured
In the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [173]
In the citing paper
“Another single-center retrospective cohort of 157 consecutive patients with a Candida BSI showed a trend toward improved survival when appropriate antifungal therapy was administered within 12 hours of blood culture collection (mortality 11.1% vs 33.1%; P 5 .169).45”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“In multivariate analysis the odds of death was 2-fold higher if adequate therapy was delayed more than 12 hours (P 5 .018).”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [45]
In the citing paper
“Invasive candidiasis occurs frequently in hospitalized patients, and is associated with high mortality rates due to delays in recognition and initiation of appropriate antifungals.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“There is extensive clinical evidence that delayed initiation of appropriate antifungal treatment is associated with increased mortality in patients with invasive candidiasis [70,71,72].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [70]
In the citing paper
“Mortality rates are estimated to be as high as 45% [16], probably due to inefficient diagnostic methods and inappropriate initial antifungal therapies [17].”
From Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents (2013) · cites this paper as [17]
In the citing paper
“The Clinical and Laboratory Standards Institute (CLSI) Subcommittee for Antifungal Testing has developed standardized broth microdilution (BMD) (169) and disk diffusion (170) methods for in vitro susceptibility testing of Candida spp.”
From Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem (2007) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Self-citationIbrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Reller, L. B. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,225
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
The Risk of Determining Risk with Multivariable Models
Concato, J., Feinstein, A. R., & Holford, T. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00009 · Cited by 1,129
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Has the Optimal Therapy for Invasive Candidiasis Now Been Defined?
Andes, D. R. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy830 · Cited by 6
Korem, M., Geffen, Y., & Amit, S. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.114896 · Cited by 6
A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2019
Stover, K. R., Chahine, E. B., Cluck, D. B., Green, S. B., Chastain, D. B., Childress, D. T., Faulkner-Fennell, C., Lusardi, K. T., McGee, E.-A. U., Turner, M., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa402 · Cited by 6
Differing Alterations of Odor Volatiles Among Pathogenic Stimuli
Millet, P., Martin, T., Opiekun, M. C., Beauchamp, G. K., & Kimball, B. A. (2021) · Chemical Senses · doi:10.1093/chemse/bjab030 · Cited by 6
Tsou, P., Yo, C., Hsein, Y.-C., Yungtum, G., Hsu, W., Chung, J.-Y., Su, K., Chang, A., Chang, I.-J., & Lee, C. (2021) · Journal of Intensive Care Medicine · doi:10.1177/08850666211053778 · Cited by 6
Camargo, J. F., Ahmed, A. A., Lindner, M. S., Morris, M. I., Anjan, S., Anderson, A. D., Prado, C. E., Dalai, S. C., Martínez, O., & Komanduri, K. V. (2019) · F1000Research · doi:10.12688/f1000research.19766.2 · Cited by 6
Vázquez-López, N. A., Cruz-Jiménez, G., Obregón-Herrera, A., Ruiz‐Baca, E., Pedraza‐Reyes, M., López-Romero, E., & Cuéllar‐Cruz, M. (2022) · Journal of Chemistry · doi:10.1155/2022/8631284 · Cited by 5
Nanobiosensors’ Potentialities for Environmental Monitoring
Kapil, S., Bhattu, M., Vinayak, A., Pal, N., & Sharma, V. (2022) · Springer eBooks · doi:10.1007/978-3-031-16106-3_3 · Cited by 6
Updates in Laboratory Identification of Invasive Fungal Infection in Neonates
He, B., & Yang, Q. (2023) · Microorganisms · doi:10.3390/microorganisms11041001 · Cited by 6
Infection Control and Prevention Considerations
Daniels, T. L., & Talbot, T. R. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-04220-6_15 · Cited by 6
Çeşitli Klinik Örneklerden İzole Edilen Kandida Türlerinin Dağılımı ve Antifungal Duyarlılıkları
Temiz, H., Temiz, S., & Kaya, S. (2015) · The Medical Journal of Okmeydani Training and Research Hospital · doi:10.5222/otd.2015.013 · Cited by 6
Tenorio, T., Grau, S., Luque, S., Fortün, J., Liaño, F., & Roberts, J. A. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000595 · Cited by 6
Nonsurgical Care of Intestinal and Multivisceral Transplant Recipients
Hopfner, R. J., Tran, T. T., Island, E. R., & McLaughlin, G. E. (2012) · Journal of Intensive Care Medicine · doi:10.1177/0885066611432425 · Cited by 6
Molecular Detection and Characterization of Fungal Pathogens
Bretagne, S. (2011) · Molecular Microbiology · doi:10.1128/9781555816834.ch42 · Cited by 6
Risk factors for Candida non-albicans candidemia
Blot, S. I., Vandijck, D. M., & Vandewoude, K. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.02.002 · Cited by 6
Moghnieh, R., Kanafani, Z. A., & Kanj, S. S. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.12.97 · Cited by 6
Park, J. Y., Yang, K. M., Kwak, J. Y., & Jung, Y. T. (2024) · Surgical Infections · doi:10.1089/sur.2023.333 · Cited by 6
ISCCM Position Statement on the Management of Invasive Fungal Infections in the Intensive Care Unit
Kumar, S., Gupta, S., Chakrabarti, A., Pande, R. K., Bhattacharya, P., Bhosale, S. J., Kumar, A. A., Mishra, V. K., Sinha, S., & Reddy, P. K. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24747 · Cited by 5
Direct Fluconazole Disk Susceptibility Testing for Candida glabrata-Positive Blood Cultures
Israel, S., Perlman, A., Moran‐Gilad, J., & Korem, M. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00311-21 · Cited by 5
Aldrees, A., Ghonem, L., Almajid, F. M., Barry, M. A., Mayet, A. Y., & Almohaya, A. M. (2021) · Antibiotics · doi:10.3390/antibiotics10121498 · Cited by 5
Lehmann, D. M., Cohen, N., Lin, I., Alexander, S., Kathuria, R., Kerpelev, M., Taur, Y., & Seo, S. K. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac555 · Cited by 5
Zhou, Y., Syed, J. H., Semchonok, D. A., Wright, E., Kyrilis, F. L., Hamdi, F., Kastritis, P. L., Bruce, B. D., & Reynolds, T. B. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104756 · Cited by 5
Terminal-stage prognostic analysis in candidemia
Takuma, T., Shoji, H., & Niki, Y. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.01.007 · Cited by 5
Mikulska, M., Furfaro, E., & Viscoli, C. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0101-2 · Cited by 5
Opciones terapéuticas para el tratamiento antifúngico en el paciente crítico
Zaragoza, R., & Pemán, J. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.009 · Cited by 6
Fluconazole-Resistant Candida : Collateral Damage Associated with Prior Antibacterial Exposure?
Ben‐Ami, R., & Giladi, M. (2012) · Future Microbiology · doi:10.2217/fmb.12.83 · Cited by 5
Skrupky, L. P., Micek, S. T., & Kollef, M. H. (2009) · Critical Care · doi:10.1186/cc8028 · Cited by 5
Self-citationDoes the current treatment of invasive fungal infection need to be reviewed?
Martín‐Peña, A., Aguilar‐Guisado, M., & Cisneros, J. M. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2013.02.008 · Cited by 5
Pharmacoeconomics of antifungal therapy: current considerations
Ashley, E. D. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000399604.68268.79 · Cited by 5
Rubach, M. P., & Hanson, K. E. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv174 · Cited by 5
Steuber, T. D., Tucker-Heard, G., Edwards, J. D., Sawyer, A., Thottacherry, E. D., & Hassoun, A. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115086 · Cited by 5
Camargo, J. F., Ahmed, A. A., Lindner, M. S., Morris, M. I., Anjan, S., Anderson, A. D., Prado, C. E., Dalai, S. C., Martínez, O., & Komanduri, K. V. (2019) · F1000Research · doi:10.12688/f1000research.19766.1 · Cited by 5
Shukla, M., Chandley, P., Kaur, H., Ghosh, A. K., Rudramurthy, S. M., & Rohatgi, S. (2021) · Journal of Fungi · doi:10.3390/jof7120999 · Cited by 6
Chandrasekar, P. H., & Ljungman, P. T. (2008) · Transplantation · doi:10.1097/tp.0b013e318177de64 · Cited by 5
Candida bloodstream infection: A clinical microbiology laboratory perspective
Pongrácz, J., & Kristóf, K. (2014) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.61.2014.3.11 · Cited by 4
Assessment of antifungal effect of omeprazole on Candida Albicans
kaslan, F. K. C. U. (2013) · International Journal for Biotechnology and Molecular Biology Research · doi:10.5897/ijbmbr2013.0157 · Cited by 5
Épidémiologie des candidoses invasives en France
Charles, P., Large, A., Quenot, J., & Dalle, F. (2016) · Réanimation · doi:10.1007/s13546-016-1183-6 · Cited by 5
Usefulness of direct fluorescent in buffy coat in the diagnosis of Candida sepsis in neonates
Higareda-Almaraz, M. A., Loza-Barajas, H., Maldonado-González, J. G., Higareda-Almaraz, E., Benítez-Godínez, V., & Murillo‐Zamora, E. (2016) · Journal of Perinatology · doi:10.1038/jp.2016.96 · Cited by 5
Gioia, A. L., Devito, A., Fiorini, F., Bombara, M., Isola, P., Spinale, B., Francioni, L., Salamone, D., Marelli, P., Buoro, S., et al. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-204078 · Cited by 5
Actualización sobre el tratamiento de las infecciones fúngicas graves
Guerra, M. (2008) · Revista española de quimioterapia. Suplemento · Cited by 5
Central nervous system mycoses: The challenges
Murthy, J. M. K. (2007) · Neurology India · doi:10.4103/0028-3886.35677 · Cited by 5
Wenzel, R. P., & Gennings, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00438-10 · Cited by 5
When Diagnostic Technology Is Ahead of the Hospital Budget: What Is Antimicrobial Stewardship to Do?
Bauer, K. A. A., & Goff, D. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ355 · Cited by 5
Vergidis, P. I., Ordaya, E. E., Porter, E., Sweet, H., Wang, W. J., Evans, A. F., Zhang, C., Young, J. H., & Liu, X. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf068 · Cited by 4
Theodore, D., Henneman, A. D., Loo, A. S., Shields, R. K., Eschenauer, G. A., Sobieszczyk, M. E., & Kubin, C. J. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae175 · Cited by 5
Caniff, K. E., Musawa, M. A., Judd, C., Shupp, M., Veve, M. P., Alangaden, G. J., Claeys, K. C., Scipione, M. R., Walsh, T. J., & Rybak, M. J. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.00043-25 · Cited by 4
Management of invasive candidiasis in nonneutropenic ICU patients
Weiss, E., & Timsit, J. (2014) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936114562586 · Cited by 5
Azap, Ö. K., & Ergönül, Ö. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810477-4.00012-x · Cited by 4
Hasan, M. J., Neelotpol, S., & Rabbani, R. (2022) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2022-0006 · Cited by 4
Management of invasive fungal infections in the pediatric intensive care unit
Fisher, B. T., Zaoutis, T. E., & Chiotos, K. (2015) · Journal of Pediatric Intensive Care · doi:10.3233/pic-14108 · Cited by 4
Laderas, J. C. P., & Pontes-Moreno, Y. A. (2011) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2011.06.004 · Cited by 4
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients
Timsit, J., Chemam, S., & Bailly, S. (2015) · F1000Prime Reports · doi:10.12703/p7-21 · Cited by 4
Wiederhold, N. P., & Herrera, L. A. (2012) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s8016 · Cited by 6
Clinical features of catheter-related candidemia at disease onset
Yoshino, Y., Wakabayashi, Y., Suzuki, S., Seo, K., Koga, I., Kitazawa, T., Okugawa, S., & Ota, Y. (2014) · Singapore Medical Journal · doi:10.11622/smedj.2014154 · Cited by 4
Infections in Intestinal and Multivisceral Transplantation
Girlanda, R., Timpone, J. G., Soriano, K. M., & Fishbein, T. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_5 · Cited by 4
Update on the Diagnosis of Candidemia and Invasive Candidiasis
González-Lara, M. F., & Ostrosky-Zeichner, L. L. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00367-1 · Cited by 4
Akgün, S., & Sayıner, H. S. (2020) · Polish Journal of Microbiology · doi:10.33073/pjm-2020-019 · Cited by 4
Qin, J., Zheng, H., Li, X., Xu, Z., Wu, W. K., Huang, D., Wang, N., Guo, Y., Zhu, Z., Liu, Y., et al. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.06.019 · Cited by 4
A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2020
Green, S. B., Stover, K. R., Barber, K. E., Bouchard, J. L., Brown, M. L., Deri, C. R., Francis, B. J., Gauthier, T. P., Hayes, J. E., Marx, A. H., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab422 · Cited by 4
Boonstra, J., van der Elst, K. C. M., Zijlstra, J. G., van der Werf, T. S., Alffenaar, J. C., & Touw, D. J. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01113-22 · Cited by 5
Post Covid-19 Sinonasal Candidiasis: A Crisis Within the Pandemic
Bhandari, S., Agarwal, S., Bhargava, S., Samdhani, S., Singh, S. N., Sharma, B. B., Malhotra, B., Bagarhatta, M., Sharma, S., Vyas, A., et al. (2022) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-022-03318-4 · Cited by 3
Tsotsolis, S., Kotoulas, S., & Lavrentieva, A. (2023) · Advances in respiratory medicine · doi:10.3390/arm91030016 · Cited by 4
Jansen, A. M. E., ter Heine, R., Verweij, P. E., & Brüggemann, R. J. M. (2023) · Clinical Pharmacokinetics · doi:10.1007/s40262-023-01311-w · Cited by 4
Impact of premix antimicrobial preparation and time to administration in septic patients
Kufel, W. D., Seabury, R. W., Meola, G., Darko, W., Probst, L. A., & Miller, C. D. (2017) · Canadian Journal of Emergency Medicine · doi:10.1017/cem.2017.33 · Cited by 4
Significance of immunotherapy for human fungal diseases and antifungal drug discovery
Mir, M. A., Jan, U., & Qadri, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00001-2 · Cited by 4
Therapie der posttraumatischen abdominellen Sepsis
Sablotzki, A., Fuchs, M., Gille, J., Weimann, A., & Czeslick, E. G. (2010) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-010-0216-z · Cited by 4
Мирчевска, Г., & Bosshard, P. P. (2012) · Macedonian Journal of Medical Sciences · doi:10.3889/mjms.1857-5773.2012.0257 · Cited by 4
Invasive fungal infections: past achievements and challenges ahead
Arendrup, M. C. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02914.x · Cited by 4
Candidiasis invasora en el paciente crítico quemado
Amaya‐Villar, R. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.010 · Cited by 4
Biomarkers for Diagnosis of Candidal Infections
Nguyen, M. H., & Clancy, C. J. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0080-8 · Cited by 4
Early Management of Sepsis, Severe Sepsis, and Septic Shock in the Surgical Patient
Kreiner, L. A., & Moore, L. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6123-4_6 · Cited by 4
Mucocutaneous and Deeply Invasive Candidiasis
Shoham, S., Nucci, M., & Walsh, T. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00088-4 · Cited by 4
Invasive candidiasis in critically ill patients
Kaaniche, F. M., Allela, R., Cherif, S., & Algia, N. B. (2016) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2016.11.002 · Cited by 4
Bretonnière, C., Lakhal, K., Lepoivre, T., Boutoille, D., & Morio, F. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.12.99 · Cited by 4
Challenges in Invasive Fungal Disease
Chakrabarti, A., & Singh, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-9349-5_18 · Cited by 4
Gong, X., Yang, M., Lin, D., Wei, H., Wang, Y., Liu, B., Zhou, C., Liu, K., Wei, S., Gong, B., et al. (2020) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2020.003 · Cited by 4
Treatment of invasive fungal infections in intensive care units with micafungin: The MYRIADE study
Timsit, J., Leverger, G., Milpied, N. J., & Gachot, B. (2020) · Mycoses · doi:10.1111/myc.13060 · Cited by 4
Opportunistic and systemic fungi
Mitchell, T. G., Verweij, P. E., & Hoepelman, A. I. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00178-7 · Cited by 4
Colombo, A. L., Guimarães, T., Camargo, L. F. A., Richtmann, R., Queiroz‐Telles, F., Salles, M. J. C., da Cunha, C. A., Shikanai‐Yasuda, M. A., Moretti, M. L., & Nucci, M. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(12)70336-7 · Cited by 4
Early Management of Sepsis, Severe Sepsis, and Septic Shock in the Surgical Patient
Scerbo, M. H., & Moore, L. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-42792-8_7 · Cited by 4
Management of Sepsis: The PIRO Approach
Rello, J., RodrÃguez, A., & Dı́az, E. (2009) · Springer eBooks · doi:10.1007/978-3-642-00479-7 · Cited by 5
Candida albicans: Clinical Relevance, Pathogenesis, and Host Immunity
Correia, A., Sampaio, P., Vilanova, M., & Pais, C. (2015) · Wiley eBooks · doi:10.1002/9781118644843.ch50 · Cited by 4
Antinori, S., Milazzo, L., Sollima, S., Galli, M., & Corbellino, M. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.09.005 · Cited by 4
Verma, N., Valsan, A., Garg, P., Sarabu, S., Kaur, P., Mohan, N., De, A., Premkumar, M., Taneja, S., Prinja, S., et al. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003832 · Cited by 3
Evolution in the Management of Invasive Fungal Infections in Liver Transplant Recipients
Verma, A., Weigel, K., Dexter, S. Y. K., & Dhawan, A. K. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1802009 · Cited by 3
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients
Zakhem, A. E., Istambouli, R., Jabbour, J.-F., Hindy, J.-R., Gharamti, A. A., & Kanj, S. S. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1741009 · Cited by 3
Consensus statement for the management of pediatric severe sepsis
日本集中治療医学会小児集中治療委員会 (2014) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.21.67 · Cited by 3
Keck, J. M., Cretella, D. A., Stover, K. R., Wagner, J. L., Barber, K. E., Jhaveri, T. A., Vijayvargiya, P., Garrigos, Z. E., & Wingler, M. J. B. (2023) · Antibiotics · doi:10.3390/antibiotics12020193 · Cited by 3
Antifungal Dosing in Critically Ill Patients
Bergman, S., Tyagi, I., & Ronald, K. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0012-z · Cited by 3
Diagnostic Radiology in Hematological Patients with Febrile Neutropenia
Heußel, C. P. (2014) · Springer eBooks · doi:10.1007/978-3-662-44000-1_7 · Cited by 3
T Cell Depleted Haploidentical Transplantation: Positive Selection
Aversa, F. (2011) · Pediatric Reports · doi:10.4081/pr.2011.s2.e14 · Cited by 3
Nouveaux marqueurs pour le diagnostic de la maladie fongique invasive
Poissy, J., Parmentier-Decrucq, E., Sendid, B., Mathieu, D., & Poulain, D. (2014) · Réanimation · doi:10.1007/s13546-014-0866-4 · Cited by 3
Intestinal/Multivisceral Transplantation
McLaughlin, G. E., & Kato, T. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6359-6_30 · Cited by 3
Fungal Infections in Cancer Patients
Granwehr, B. P., & Kontoyiannis, D. P. (2021) · Springer eBooks · doi:10.1007/978-3-319-74698-2_121-2 · Cited by 3
Characteristics and Incidence of Candidemia in Hospitalized Coronavirus 2019 (COVID-19) Patients
Boachie, N., Johnston, J. P., Philip, S. A., Sullivan, K. V., & Heaney, M. (2022) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2022.1.8 · Cited by 3
Clinical utility of time to positivity of blood cultures in cases of fungaemia: A prospective study
Kaur, H., Kanaujia, R., Singh, S., Kajal, K., Jayashree, M., Peter, N. J., Verma, S., Gupta, M., Ray, P., Ghosh, A. K., et al. (2022) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2022.08.014 · Cited by 4
Zou, Z.-Y., Sun, K.-J., Fu, G., Huang, J.-J., Yang, Z.-J., Zhou, Z.-P., Ma, S., Zhu, F., & Wu, M. T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1047889 · Cited by 3
Ostrowski, J., Paterson, D. L., Lipman, J., & Udy, A. A. (2012) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1204000509 · Cited by 3
Maldonado, I., Canigia, L. F., Vivot, W., Domecq, P., Davel, G., & Córdoba, S. B. (2011) · PubMed · doi:10.1590/s0325-75412011000200010 · Cited by 3
Anidulafungin: Review of its Role in the Treatment of Invasive Candidiasis
de la Torre, P., & Reboli, A. C. (2011) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s3153 · Cited by 3
Metadata
- Authors
- Morrell, M., Fraser, V. J., & Kollef, M. H.
- Affiliations
- Washington University in St. Louis (US)
- Pulmonary and Critical Care Division
- Corresponding author
- Kollef, Marin H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-09
- Volume
- 49
- Issue
- 9
- Pages
- 3640-3645
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1195428
- OpenAlex
- W2137575148
- Cited by
- 1,286
- References
- 47
- Citations by year
- 2026: 33 · 2025: 33 · 2024: 41 · 2023: 33 · 2022: 53 · 2021: 51 · 2020: 58 · 2019: 63 · 2018: 65 · 2017: 67 · 2016: 71 · 2015: 77 · 2014: 97 · 2013: 75 · 2012: 78
- FWCI
- 27.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- candidemia, fungemia, empirical antifungal therapy, treatment delay, blood culture, in-hospital mortality, APACHE II score, prior antibiotic use, rapid diagnostic tests
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candidiasis, Cross Infection, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Cohort Studies, Logistic Models, Fungemia, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
